Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -7 of 7
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase III Chemotherapy with Fluoxymesterone, Oxymetholone, Testosterone and Splenectomy for Myeloproliferative Disorders and Refractory Anemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Completed
no age specified
PVSG-2
Last Modified:
10/23/2008
 
First Published:
12/23/2003
2.
Phase III Randomized Study of Low-Dose Testosterone to Enhance Libido in Postmenopausal Female Cancer Survivors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Completed
Postmenopausal
NCI
NCCTG-N02C3
NCT00075855
Last Modified:
7/25/2008
 
First Published:
9/24/2003
3.
Phase II Study of Rapid Hormonal Cycling With Testosterone and Leuprolide in Combination With Docetaxel in Patients With Recurrent or Non-Castrate Metastatic Adenocarcinoma of the Prostate
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
MSKCC-03076
NCT00070369
4.
Testosterone in Castration-Resistant Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
Not specified
Other
2006-0316
NCT00577980
Last Modified:
8/11/2004
 
First Published:
7/1/2000
5.
Phase I Study of Testosterone in Patients With Progressive Androgen-Independent Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
NCI
MSKCC-99115
NCI-G00-1818, NCT00006044
6.
Chemotherapy with Oxymetholone or Testosterone Enanthate for Resistant Anemias Due to Myeloproliferative Disorders
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Closed
no age specified
PVSG-11
7.
Chemotherapy with L-PAM, L-PAM/PRED, and Testosterone Enanthate for Multiple Myeloma
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Completed
no age specified
NCI
CLB-6501
EST-0465
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute